IRWD icon

Ironwood Pharmaceuticals
IRWD

Overview Fund Activity

167 hedge funds and large institutions have $2.78B invested in Ironwood Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 63 increasing their positions, 51 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
+5
Holders Change %
+3.09%
% of All Funds
4.17%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
22
Increased
63
Reduced
51
Closed
16
Calls
$4.66M
Puts
$3.6M
Net Calls
+$1.06M
Net Calls Change
+$1.72M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
$150M
2
UBS AM
UBS AM
Illinois
$68M
3
BCM
Brown Capital Management
Maryland
$117M
4
EC
EcoR1 Capital
California
$70.9M
5
PCM
Penn Capital Management
Pennsylvania
$16.3M

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$64.7M
2
O
OrbiMed
New York
$109M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$15.9M
4
RCMNY
Rubric Capital Management (New York)
New York
$0
5
Fidelity Investments
Fidelity Investments
Massachusetts
$353M
Name Holding Trade Value Shares
Change 		Shares
Change %
CCIA
176
Campbell & Co Investment Adviser
Maryland
– -$245K -17,173 Closed
Squarepoint
177
Squarepoint
New York
– -$221K -15,459 Closed
GCA
178
Gideon Capital Advisors
New York
– -$191K -13,387 Closed
GKWIM
179
Gerber Kawasaki Wealth & Investment Management
California
– -$165K -12,010 Closed
AIM
180
Acrospire Investment Management
Illinois
– -$81K -5,644 Closed
CSS
181
Cubist Systematic Strategies
Connecticut
– -$50K -3,504 Closed
SCM
182
Segantii Capital Management
Hong Kong
– -$49K -3,463 Closed
4 5 6 7
8